Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00045474 · ClinicalTrials.gov registry record · Phase 1
Brachytherapy in Treating Patients With Recurrent Malignant Glioma
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00045474: Completed Phase 1 study, sponsored by National Cancer Institute (NCI).
NCT00045474 is a Phase 1 study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00045474, a Phase 1 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Brachytherapy uses radioactive material to kill cancer cells remaining after surgery. PURPOSE: Phase I trial to study the effectiveness of brachytherapy in treating patients who have recurrent malignant glioma.
Interventions
- PROCEDURE adjuvant therapy
- RADIATION iodine I 125
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00045474
The ClinicalTrials.gov registry entry for NCT00045474 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which adjuvant therapy is the first listed.
NCT00045474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00045474 about?
NCT00045474 is a clinical study titled "Brachytherapy in Treating Patients With Recurrent Malignant Glioma". RATIONALE: Brachytherapy uses radioactive material to kill cancer cells remaining after surgery. PURPOSE: Phase I trial to study the effectiveness of brachytherapy in treating patients who have recurrent malignant glioma.
What is the current status of trial NCT00045474?
This trial is currently completed. It is a Phase 1 study. The study started on 2002-10.
What interventions are being tested in trial NCT00045474?
The interventions under investigation include: adjuvant therapy (PROCEDURE), iodine I 125 (RADIATION).
Who is sponsoring clinical trial NCT00045474?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.